相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role for Fgr and Numb in retinoic acid-induced differentiation and G0 arrest of non-APL AML cells
Noor Kazim et al.
Oncotarget (2021)
The role of bosutinib in the treatment of chronic myeloid leukemia
Carlo Gambacorti-Passerini et al.
FUTURE ONCOLOGY (2020)
Roscovitine enhances all-trans retinoic acid (ATRA)-induced nuclear enrichment of an ensemble of activated signaling molecules and augments ATRA-induced myeloid cell differentiation
Asif Rashid et al.
Oncotarget (2020)
Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment
Rodica P. Bunaciu et al.
ONCOTARGET (2018)
Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells
Robert J. MacDonald et al.
LEUKEMIA & LYMPHOMA (2018)
An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program
Ryan Tasseff et al.
SCIENTIFIC REPORTS (2017)
Optimizing Therapy for Acute Myeloid Leukemia
Holbrook E. Kohrt et al.
Journal of the National Comprehensive Cancer Network (2017)
Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout
Robert J. MacDonald et al.
SCIENTIFIC REPORTS (2017)
Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation
Noriyoshi Iriyama et al.
CANCER CELL INTERNATIONAL (2016)
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib
Richat Abbas et al.
CLINICAL PHARMACOKINETICS (2016)
RRD-251 enhances All-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells
Aaron S. Wallace et al.
ONCOTARGET (2016)
An ATRActive future for differentiation therapy in AML
Daniel E. Johnson et al.
BLOOD REVIEWS (2015)
The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells
Christopher N. Ibabao et al.
FEBS OPEN BIO (2015)
Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity
Johanna Congleton et al.
CELLULAR SIGNALLING (2014)
Retinoic Acid Therapy Resistance Progresses from Unilineage to Bilineage in HL-60 Leukemic Blasts
Holly A. Jensen et al.
PLOS ONE (2014)
Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic
Muneera Al-Hussaini et al.
EXPERT REVIEW OF HEMATOLOGY (2014)
Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines
Hidetomo Kikuchi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
Jeremy S. Logue et al.
GENES & DEVELOPMENT (2012)
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
J. Congleton et al.
LEUKEMIA (2012)
Activation of the Aryl Hydrocarbon Receptor AhR Promotes Retinoic Acid-Induced Differentiation of Myeloblastic Leukemia Cells by Restricting Expression of the Stem Cell Transcription Factor Oct4
Rodica P. Bunaciu et al.
CANCER RESEARCH (2011)
Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias
Bella S. Guerrouahen et al.
CLINICAL CANCER RESEARCH (2010)
Dasatinib promotes ATRA-induced differentiation of AML cells
P. L. Kropf et al.
LEUKEMIA (2010)
Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis
M. P. Kim et al.
CELL AND TISSUE RESEARCH (2009)
Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells
James Smith et al.
EXPERIMENTAL CELL RESEARCH (2009)
c-Cbl Tyrosine Kinase-binding Domain Mutant G306E Abolishes the Interaction of c-Cbl with CD38 and Fails to Promote Retinoic Acid-induced Cell Differentiation and Go Arrest
Miaoqing Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Src kinases as therapeutic targets for cancer
Lori C. Kim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
c-CbI Interacts with CD38 and Promotes Retinoic Acid-Induced Differentiation and G0 Arrest of Human Myeloblastic Leukemia Cells
Miaoqing Shen et al.
CANCER RESEARCH (2008)
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
Adina Vultur et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest
Jianrong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Retinoic acid induces expression of SLP-76: Expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells
A Yen et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2006)
Vav promotes differentiation of human tumoral myeloid precursors
V Bertagnolo et al.
EXPERIMENTAL CELL RESEARCH (2005)
Vav 1: an oncogene that regulates specific transcriptional activation of T cells
S Katzav
BLOOD (2004)
Src family kinases, key regulators of signal transduction
SJ Parsons et al.
ONCOGENE (2004)
Retinoids in cancer therapy and chemoprevention: promise meets resistance
SJ Freemantle et al.
ONCOGENE (2003)
Phosphorylation of the linker for activation of T-cells by Itk promotes recruitment of Vav
JJ Perez-Villar et al.
BIOCHEMISTRY (2002)
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity
DH Boschelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Regulatory and signaling properties of the Vav family
XR Bustelo
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
